What is the difference between HGH peptides and synthetic HGH?

Synthetic HGH (somatropin, HGH 191aa) is the full 191-amino-acid growth hormone molecule administered directly, which suppresses the body's own GH production over time. HGH peptides are secretagogues that signal the pituitary to produce GH naturally, preserving the pulsatile release pattern and endogenous regulation. Peptides are generally considered lower-risk and are significantly less expensive than pharmaceutical HGH.

HGH 191aa refers to recombinant human growth hormone — the synthetic 191-amino-acid sequence identical to endogenous somatotropin. Unlike GH secretagogue peptides (such as sermorelin or ipamorelin), HGH 191aa directly supplies growth hormone rather than stimulating the pituitary to produce it. Pharmaceutical versions include Norditropin, Genotropin, and Humatrope.

How much does HGH peptide therapy cost?

HGH peptide therapy (secretagogue protocols such as sermorelin or ipamorelin + CJC-1295) typically costs $150–$500 per month depending on the peptide, dosing frequency, and provider type. This is substantially less than pharmaceutical HGH, which can cost $500–$2,000+ per month. Telehealth platforms tend to offer lower prices than traditional clinics.

What does HGH peptide research show about body composition?

Research on GH secretagogues has demonstrated improvements in lean body mass, reductions in visceral fat, improved sleep quality, and faster recovery in various study populations. Sermorelin trials showed increased IGF-1 levels and lean mass after 6 months. Ipamorelin studies noted improved GH pulsatility with fewer side effects than GHRP-2 or hexarelin. Results vary by individual, baseline GH status, age, and lifestyle factors.

Guide

HGH peptides: GH secretagogues explained

Q: What are HGH peptides?

HGH peptides are growth hormone secretagogues (GHS) — compounds that stimulate the pituitary gland to release endogenous growth hormone. They do not contain synthetic HGH. The main classes are GHRH analogs (such as sermorelin and CJC-1295) and GH-releasing peptides (GHRPs such as ipamorelin and hexarelin).

“HGH peptides” are growth hormone secretagogues — compounds that signal the pituitary to release endogenous GH. They are not synthetic HGH. Here is how they work, how they compare, and what the research shows.

Educational research tools — not medical advice.

What are HGH peptides?

The term “HGH peptides” is commonly used to describe growth hormone secretagogues (GHS) — a class of compounds that stimulate the anterior pituitary gland to produce and release growth hormone (GH) naturally. Despite the name, they do not contain human growth hormone.

There are two primary mechanistic classes:

→GHRH analogs: Mimic growth hormone-releasing hormone (GHRH), the hypothalamic signal that triggers pituitary GH release. Examples: sermorelin, CJC-1295, tesamorelin.
→GH-releasing peptides (GHRPs): Activate the ghrelin receptor (GHS-R1a) on pituitary cells, producing a separate GH-stimulating signal that acts synergistically with GHRH. Examples: ipamorelin, hexarelin, GHRP-6.

Stacking a GHRH analog with a GHRP (e.g., CJC-1295 + ipamorelin) produces synergistic GH release — the two signals converge on the pituitary through different receptors, amplifying the GH pulse beyond what either compound produces alone.

Peptides vs HGH: what is the difference?

Synthetic HGH (somatropin, commonly sold as “HGH 191aa”) is the full 191-amino-acid human growth hormone molecule produced via recombinant DNA technology. It replaces GH directly. GH secretagogue peptides signal the body to produce its own GH.

Aspect	GH secretagogue peptides	Synthetic HGH (191aa)
Mechanism	Stimulates pituitary to release endogenous GH	Directly replaces GH; bypasses pituitary
GH release pattern	Pulsatile — mirrors natural rhythm	Continuous (supraphysiological between doses)
Endogenous suppression	Minimal to none	Suppresses natural GH production over time
IGF-1 elevation	Moderate, dose-dependent	Significant — primary anabolic driver
Typical monthly cost	$150–$500	$500–$2,000+
Regulatory status	Research compounds (except sermorelin, tesamorelin)	Prescription pharmaceutical (somatropin)

HGH 191aa is a pharmaceutical product (somatropin). GH secretagogues are research compounds except for sermorelin and tesamorelin, which have prior FDA approval history.

Types of HGH peptides

The following are the most studied GH secretagogues and HGH-related peptides. Each has a distinct mechanism, receptor profile, and research context.

Sermorelin

GHRH analog

Binds GHRH receptor on pituitary to stimulate GH release

Oldest clinically studied GH secretagogue; FDA-approved history (Geref)

View Sermorelin profile

CJC-1295

GHRH analog (modified)

Extended half-life GHRH analog; binds albumin to resist enzymatic cleavage

Often stacked with ipamorelin for synergistic GH pulse

View CJC-1295 profile

Tesamorelin

GHRH analog (stabilized)

Full-length GHRH analog with trans-2-hexenoic acid conjugation

FDA-approved (Egrifta) for HIV-associated lipodystrophy

View Tesamorelin profile

Ipamorelin

GHRP (selective)

Selective ghrelin receptor agonist; minimal cortisol/prolactin side effects

Most selective GHRP; preferred for protocols requiring clean GH pulse

View Ipamorelin profile

Hexarelin

GHRP

Potent ghrelin receptor agonist with additional cardiac GH-independent effects

Stronger GH release than ipamorelin; more pronounced cortisol increase

View Hexarelin profile

HGH Fragment 176-191

HGH fragment

C-terminal fragment of HGH; modulates fat metabolism without IGF-1 effects

Specifically targets adipose tissue; no anabolic GH effects

View HGH Fragment 176-191 profile

HGH peptides before and after: what research shows

GH secretagogue research has examined body composition, metabolic markers, sleep quality, and recovery in various populations. Key findings across published studies:

Lean body mass

Sermorelin trials in GH-deficient adults reported significant increases in lean mass after 6 months of twice-daily subcutaneous injection, along with increased IGF-1 levels. CJC-1295 studies showed dose-dependent IGF-1 elevation lasting up to 14 days per injection.

Visceral fat reduction

Tesamorelin (FDA-approved in HIV lipodystrophy) produced a 17–18% reduction in visceral adipose tissue in randomized controlled trials at 2 mg/day. HGH Fragment 176-191 (AOD-9604) demonstrated selective adipose tissue metabolism effects in preclinical and early phase trials.

Sleep quality

GHRPs including ipamorelin stimulate slow-wave sleep (SWS), during which endogenous GH peaks naturally. Research subjects reported subjectively improved sleep onset and depth. DSIP (a separate delta sleep-inducing peptide) also targets this pathway.

Recovery

GH supports connective tissue repair, collagen synthesis, and muscle protein turnover. Studies on GH-deficient populations show improved recovery markers; data in healthy, GH-sufficient individuals is more limited.

Individual results depend on baseline GH status, age, body composition, dose, and protocol. Most robust evidence comes from GH-deficient or clinical populations. Evidence in healthy adults with normal GH is limited. None of the above constitutes medical advice.

HGH peptide therapy cost

GH secretagogue protocols cost significantly less than pharmaceutical HGH. Typical monthly ranges:

Protocol	Typical monthly cost
Sermorelin (monotherapy)	$150–$300 / month
Ipamorelin + CJC-1295 (combo)	$200–$400 / month
Tesamorelin	$350–$600 / month
Pharmaceutical HGH (somatropin)	$500–$2,000+ / month

Telehealth platforms typically price lower than brick-and-mortar clinics. Costs include the peptide, syringes, and in some cases initial consultation and labs. Insurance does not typically cover GH secretagogue protocols.

Frequently asked questions

What is HGH 191aa?

HGH 191aa is recombinant human growth hormone — the synthetic 191-amino-acid sequence identical to endogenous somatotropin. Unlike GH secretagogues (sermorelin, ipamorelin), it directly supplies growth hormone rather than stimulating the pituitary to produce it. Pharmaceutical versions include Norditropin, Genotropin, and Humatrope.

Can you stack two HGH peptides?

Yes — the most common stack combines a GHRH analog (CJC-1295 or sermorelin) with a GHRP (ipamorelin). They act on different receptors and produce a synergistic GH pulse larger than either compound alone. This is the most commonly prescribed GH secretagogue combination in telehealth contexts.

How long do HGH peptide effects last?

GH pulse duration depends on the peptide's half-life. Sermorelin produces a pulse lasting 20–30 minutes. CJC-1295 with DAC has an extended half-life of 6–8 days per injection. IGF-1 elevation — the downstream anabolic signal — persists longer (days to weeks) regardless of the peptide used.

How to reconstitute GH secretagogues

Calculate BAC water volume, concentration, and draw volume for any peptide vial.

Calculator

Peptide dosage guide

How dose is calculated and what factors affect GH secretagogue protocols.

Read guide

Looking for a GH peptide provider?

Browse verified clinics, telehealth platforms, and compounding pharmacies offering GH secretagogue protocols on PeptideBase.

Browse the directory